When it comes to diseases like liver cancer, early detection is very important for a high chance of recovery and remission. A way to detect for an indicator of the condition is through what is being flushed down the toilet, specifically, the stools.
Much like other cancers, symptoms become more evident as cancer progresses, so it is important to spot them and see a doctor right away. Express reports that a sign of liver cancer may be found in the stool or the color of the stool. Experts say that if the stool looks white and chalky, then it may be a sign of the cancer. This may be because the liver is not producing enough bile - the substance that turns stools into varying shades of brown - so it can indicate a problem with the liver and or bile ducts. In the same vein, pale stools that follow or are followed by a change in the color of the urine may also indicate issues with the liver.
However, much like any other condition, symptoms overlap with one another, so this kind of change in the stool or urine may indicate some other condition, such as an infection. It is highly advised to see a doctor right away in case this happens.
But when the stool changes color, it does not necessarily mean a condition right away. The stool’s color will vary depending on the food one eats, or the kind of medication one takes. Certain types of food have been known to change the color of the stool once digested in the body, so it may not be a cause of concern just yet.
One example of which is beets. Beets are known for their purplish-red hue and are also known to stain hands and fingers if a person is cutting into them. Eating beets will result in having a dark red-hued stool, which may look like blood. If not in the stool, the pigment found in beets may show up a little bit in the urine as well, which can seem alarming.
Green veggies have also been known to change the stool color due to the chlorophyll present in them that give the veggies their green color. Blueberries are also culprits of resulting in unusual stool colors.


Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 



